Mice deficient in MIM expression are predisposed to lymphomagenesis

Oncogene

Volumn 31, Issue 30, 2012, Pages 3561-3568

  Yu, D ^a   Zhan, X H ^a   Zhao, X F ^a   Williams, M S ^a   Carey, G B ^a   Smith, E ^a   Scott, D ^b   Zhu, J ^c   Guo, Y ^a   Cherukuri, S ^a   Civin, C I ^a   Zhan, X ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^c NANTONG UNIVERSITY   (China)

Author keywords

B cells; chemokine; I BAR; lymphoma; MIM

Indexed keywords

ACTIN; CHEMOKINE RECEPTOR CXCR5; CXCL13 CHEMOKINE; PROTEIN MIM; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

ACUTE LYMPHOBLASTIC LEUKEMIA; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; BONE MARROW; CARCINOGENESIS; CELL LINEAGE; CHEMOTAXIS; CONTROLLED STUDY; FEMALE; HISTOLOGY; HUMAN; HUMAN CELL; KNOCKOUT MOUSE; LARGE CELL LYMPHOMA; LYMPHOID ORGAN; LYMPHOMAGENESIS; MALE; MICROARRAY ANALYSIS; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FAMILY; SPLENOMEGALY; TUMOR MICROENVIRONMENT;

ANIMALS; B-LYMPHOCYTES; BONE MARROW; CELL TRANSFORMATION, NEOPLASTIC; CELLS, CULTURED; CHEMOKINE CXCL13; CHEMOTAXIS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GRANULOCYTES; HUMANS; LEUKOCYTES, MONONUCLEAR; LYMPHOMA, LARGE B-CELL, DIFFUSE; MALE; MICE; MICE, KNOCKOUT; MICROFILAMENT PROTEINS; NEOPLASM PROTEINS; RECEPTORS, CXCR5; SPLEEN; T-LYMPHOCYTES;

MUS;

EID: 84864329795     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2011.509     Document Type: Article

References (44)

1. Bailey JM, Singh PK, Hollingsworth MA. (2007). Cancer metastasis facilitated by developmental pathways: Sonic hedgehog, Notch, and bone morphogenic proteins. J Cell Biochem 102: 829-839. (Pubitemid 350036923)
2. Bodenstine TM, Welch DR. (2008). Metastasis suppressors and the tumor microenvironment. Cancer Microenviron 1: 1-11.
3. Bompard G, Sharp SJ, Freiss G, Machesky LM. (2005). Involvement of Rac in actin cytoskeleton rearrangements induced by MIM-B. J Cell Sci 118: 5393-5403. (Pubitemid 41819600)
4. Callahan CA, Ofstad T, Horng L, Wang JK, Zhen HH, Coulombe PA Et al. (2004). MIM/BEG4, a Sonic hedgehog-responsive gene that potentiates Gli-dependent transcription. Genes Dev 18: 2724-2729. (Pubitemid 39507765)
5. Chang Y, Paige CJ, Wu GE. (1992). Enumeration and characterization of DJH structures in mouse fetal liver. EMBO J 11: 1891-1899.
6. Dierks C, Grbic J, Zirlik K, Beigi R, Englund NP, Guo GR et al. (2007). Essential role of stromally induced hedgehog signaling in B-cell malignancies. Nat Med 13: 944-951. (Pubitemid 47222041)
7. Egeblad M, Nakasone ES, Werb Z. (2010). Tumors as organs: complex tissues that interface with the entire organism. Dev Cell 18: 884-901.
8. Frost A, Unger VM, De Camilli P. (2009). The BAR domain superfamily: membrane-molding macromolecules. Cell 137: 191-196.
9. Gallop JL, McMahon HT. (2005). BAR domains and membrane curvature: bringing your curves to the BAR. Biochem Soc Symp 72: 223-231. (Pubitemid 44804748)
10. Gribben JG. (2010). Implications of the tumor microenvironment on survival and disease response in follicular lymphoma. Curr Opin Oncol 22: 424-430.
11. Karnoub AE, Weinberg RA. (2006). Chemokine networks and breast cancer metastasis. Breast Dis 26: 75-85. (Pubitemid 46647416)
12. LeBien TW, Tedder TF. (2008). B lymphocytes: how they develop and function. Blood 112: 1570-1580.
13. Lee SH, Kerff F, Chereau D, Ferron F, Klug A, Dominguez R. (2007). Structural basis for the actin-binding function of missing-inmetastasis. Structure 15: 145-155. (Pubitemid 46209813)
14. Lee YG, Macoska JA, Korenchuk S, Pienta KJ. (2002). MIM, a potential metastasis suppressor gene in bladder cancer. Neoplasia 4: 291-294. (Pubitemid 34755838)
15. Liang H, Chen Q, Coles AH, Anderson SJ, Pihan G, Bradley A et al. (2003). Wnt5a inhibits B cell proliferation and functions as a tumor suppressor in hematopoietic tissue. Cancer Cell 4: 349-360. (Pubitemid 37491096)
16. Lin J, Liu J, Wang Y, Zhu J, Zhou K, Smith N et al. (2005). Differential regulation of cortactin and N-WASP-mediated actin polymerization by missing in metastasis (MIM) protein. Oncogene 24: 2059-2066. (Pubitemid 40516199)
17. Lindemann RK. (2008). Stroma-initiated hedgehog signaling takes center stage in B-cell lymphoma. Cancer Res 68: 961-964. (Pubitemid 351272211)
18. Lipp M, Muller G. (2004). Lymphoid organogenesis: getting the green light from RORgamma(t). Nat Immunol 5: 12-14. (Pubitemid 38081461)
19. Liu K, Wang G, Ding H, Chen Y, Yu G, Wang J. (2010). Downregulation of metastasis suppressor 1(MTSS1) is associated with nodal metastasis and poor outcome in Chinese patients with gastric cancer. BMC Cancer 10: 428.
20. Liu W, Komiya Y, Mezzacappa C, Khadka DK, Runnels L, Habas R. (2011). MIM regulates vertebrate neural tube closure. Development 138: 2035-2047.
21. Loberg RD, Neeley CK, Adam-Day LL, Fridman Y, St John LN, Nixdorf S et al. (2005). Differential expression analysis of MIM (MTSS1) splice variants and a functional role of MIM in prostate cancer cell biology. Int J Oncol 26: 1699-1705.
22. Ma S, Guan XY, Lee TK, Chan KW. (2007). Clinicopathological significance of missing in metastasis B expression in hepatocellular carcinoma. Hum Pathol 38: 1201-1206. (Pubitemid 47058158)
23. Mahadevan D, Spier C, Della Croce K, Miller S, George B, Riley C et al. (2005). Transcript profiling in peripheral T-cell lymphoma, not otherwise specified, and diffuse large B-cell lymphoma identifies distinct tumor profile signatures. Mol Cancer Ther 4: 1867-1879. (Pubitemid 43056970)
24. Martensson IL, Almqvist N, Grimsholm O, Bernardi AL. (2010). The pre-B cell receptor checkpoint. FEBS Lett 584: 2572-2579.
25. Mattila PK, Pykalainen A, Saarikangas J, Paavilainen VO, Vihinen H, Jokitalo E et al. (2007). Missing-in-metastasis and IRSP53 deform PI(4,5)P2-rich membranes by an inverse BAR domain-like mechanism. J Cell Biol 176: 953-964. (Pubitemid 46506969)
26. McAllister SS, Weinberg RA. (2010). Tumor-host interactions: a farreaching relationship. J Clin Oncol 28: 4022-4028.
27. Middendorp S, Xiao Y, Song JY, Peperzak V, Krijger PH, Jacobs H et al. (2009). Mice deficient for CD137 ligand are predisposed to develop germinal center-derived B-cell lymphoma. Blood 114: 2280-2289.
28. Millard TH, Bompard G, Heung MY, Dafforn TR, Scott DJ, Machesky LM et al. (2005). Structural basis of filopodia formation induced by the IRSP53/MIM homology domain of human IRSP53. EMBO J 24: 240-250. (Pubitemid 40216129)
29. Morse III HC, Anver MR, Fredrickson TN, Haines DC, Harris AW, Harris NL et al. (2002). Bethesda proposals for classification of lymphoid neoplasms in mice. Blood 100: 246-258. (Pubitemid 35177454)
30. Nixdorf S, Grimm MO, Loberg R, Marreiros A, Russell PJ, Pienta KJ et al. (2004). Expression and regulation of MIM (missing in metastasis), a novel putative metastasis suppressor gene, and MIMB, in bladder cancer cell lines. Cancer Lett 215: 209-220. (Pubitemid 39370039)
31. Nowee ME, Snijders AM, Rockx DA, de Wit RM, Kosma VM, Hamalainen K et al. (2007). DNA profiling of primary serous ovarian and fallopian tube carcinomas with array comparative genomic hybridization and multiplex ligation-dependent probe amplification. J Pathol 213: 46-55.
32. Parr C, Jiang WG. (2009). Metastasis suppressor 1 (MTSS1) demonstrates prognostic value and anti-metastatic properties in breast cancer. Eur J Cancer 45: 1673-1683.
33. Quinones GA, Oro AE. (2010). BAR domain competition during directional cellular migration. Cell Cycle 9: 2522-2528.
34. Rolink AG. (2004). B-cell development and pre-B1 cell plasticity in vitro. Methods Mol Biol 271: 271-281.
35. Saarikangas J, Mattila PK, Varjosalo M, Bovellan M, Hakanen J, Calzada-Wack J et al. (2011). Missing-in-metastasis MIM/MTSS1 promotes actin assembly at intercellular junctions and is required for integrity of kidney epithelia. J Cell Sci 124: 1245-1255.
36. Scita G, Confalonieri S, Lappalainen P, Suetsugu S. (2008). IRSP53: crossing the road of membrane and actin dynamics in the formation of membrane protrusions. Trends Cell Biol 18: 52-60.
37. Shaffer AL, Rosenwald A, Staudt LM. (2002). Lymphoid malignancies: the dark side of B-cell differentiation. Nat Rev Immunol 2: 920-932. (Pubitemid 37323213)
38. Su Y, Carey G, Maric M, Scott DW. (2008). B cells induce tolerance by presenting endogenous peptide-IgG on MHC class II molecules via an IFN-gamma-inducible lysosomal thiol reductase-dependent pathway. J Immunol 181: 1153-1160.
39. Wang D, Xu MR, Wang T, Li T, Zhu JW. (2011). MTSS1 overexpression correlates with poor prognosis in colorectal cancer. J Gastrointest Surg 15: 1205-1212.
40. Wang Y, Liu J, Smith E, Zhou K, Liao J, Yang GY et al. (2007). Downregulation of missing in metastasis gene (MIM) is associated with the progression of bladder transitional carcinomas. Cancer Invest 25: 79-86. (Pubitemid 46598167)
41. Woodings JA, Sharp SJ, Machesky LM. (2003). MIM-B, a putative metastasis suppressor protein, binds to actin and to protein tyrosine phosphatase delta. Biochem J 371: 463-471. (Pubitemid 36547630)
42. Xia S, Li X, Johnson T, Seidel C, Wallace DP, Li R. (2010). Polycystin-dependent fluid flow sensing targets histone deacetylase 5 to prevent the development of renal cysts. Development 137: 1075-1084.
43. Yu D, Zhan XH, Niu S, Mikhailenko I, Strickland DK, Zhu J et al. (2011). Murine missing in metastasis mediates cell polarity and regulates the motility response to growth factors. PLoS One 6: e20845.
44. Yu J, Ma X, Cheung KF, Li X, Tian L, Wang S et al. (2010). Epigenetic inactivation of T-box transcription factor 5, a novel tumor suppressor gene, is associated with colon cancer. Oncogene 29: 6464-6474.